- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Madrigal Pharmaceuticals
Market Cap: US$10.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$440.83
7D
1.8%
1Y
28.7%
Ascendis Pharma
Market Cap: US$13.9b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$231.03
7D
-3.7%
1Y
36.8%
Insmed
Market Cap: US$30.1b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$144.60
7D
1.0%
1Y
85.9%
Alnylam Pharmaceuticals
Market Cap: US$41.6b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$318.91
7D
-1.4%
1Y
26.0%
BeOne Medicines
Market Cap: US$31.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$289.65
7D
-4.2%
1Y
9.3%
BridgeBio Pharma
Market Cap: US$13.5b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$71.03
7D
8.2%
1Y
115.2%
Ionis Pharmaceuticals
Market Cap: US$11.8b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$72.34
7D
-4.0%
1Y
110.9%
AbbVie
Market Cap: US$388.4b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$221.45
7D
-2.6%
1Y
3.3%
Jazz Pharmaceuticals
Market Cap: US$11.0b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$182.02
7D
-1.8%
1Y
29.8%
Eli Lilly
Market Cap: US$880.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$989.12
7D
-1.9%
1Y
19.9%
BioMarin Pharmaceutical
Market Cap: US$11.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$57.43
7D
-5.7%
1Y
-19.7%
Natera
Market Cap: US$26.6b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$197.68
7D
-3.7%
1Y
32.4%
Royalty Pharma
Market Cap: US$26.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$46.10
7D
0.6%
1Y
39.6%
Viatris
Market Cap: US$15.6b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.51
7D
-5.0%
1Y
46.1%
Exact Sciences
Market Cap: US$19.8b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$103.85
7D
0.1%
1Y
129.9%
Elanco Animal Health
Market Cap: US$11.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.40
7D
-2.3%
1Y
119.9%
Waters
Market Cap: US$28.1b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$290.02
7D
-5.1%
1Y
-23.5%